|
DE2611690A1
(de)
*
|
1976-03-19 |
1977-09-22 |
Goedecke Ag |
Cyclische sulfonyloxyimide
|
|
JPS5776189U
(fr)
*
|
1980-10-28 |
1982-05-11 |
|
|
|
JPS6152583U
(fr)
*
|
1984-09-11 |
1986-04-09 |
|
|
|
JPS61139881U
(fr)
*
|
1985-02-21 |
1986-08-29 |
|
|
|
US4876279A
(en)
*
|
1986-05-05 |
1989-10-24 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
|
US4894476A
(en)
*
|
1988-05-02 |
1990-01-16 |
Warner-Lambert Company |
Gabapentin monohydrate and a process for producing the same
|
|
US4960931A
(en)
*
|
1988-05-02 |
1990-10-02 |
Warner-Lambert Company |
Gabapentin mohohydrate and a process for producing the same
|
|
YU162789A
(en)
*
|
1988-09-01 |
1990-12-31 |
Lonza Ag |
2-aza-4-(alcoxycarbonyl) spiro/4,5/decan-3-ones
|
|
US5319135A
(en)
*
|
1989-08-25 |
1994-06-07 |
Warner-Lambert Company |
Process for cyclic amino acid anticonvulsant compounds
|
|
DE3928182A1
(de)
*
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Verfahren zur herstellung von gabapentin
|
|
DE3928183A1
(de)
*
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Lactamfreie cyclische aminosaeuren
|
|
US5132451A
(en)
*
|
1989-08-25 |
1992-07-21 |
Warner-Lambert Company |
Process for cyclic amino acid anticonvulsant compounds
|
|
DE3928184A1
(de)
*
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
|
|
MY106864A
(en)
*
|
1989-08-25 |
1995-08-30 |
Warner Lambert Co |
Improved process for cyclic amino acid anticonvulsant compounds.
|
|
US5260467A
(en)
*
|
1989-11-16 |
1993-11-09 |
Pfizer Inc. |
Glutaric acid derivatives and preparation thereof
|
|
FI905584A7
(fi)
*
|
1989-11-16 |
1991-05-17 |
Lonza Ag |
Menetelmä 1-(aminometyyli)sykloheksaanietikkahapon valmistamiseksi
|
|
US5136091A
(en)
*
|
1989-11-16 |
1992-08-04 |
Lonza Ltd. |
Process for the production of 1-(aminomethyl) cyclohexane acetic acid
|
|
GB8925933D0
(en)
*
|
1989-11-16 |
1990-01-04 |
Pfizer Ltd |
Glutaric acid derivatives and preparation thereof
|
|
US5157138A
(en)
*
|
1989-11-16 |
1992-10-20 |
Pfizer, Inc. |
Glutaric acid derivatives and preparation thereof
|
|
US5149870A
(en)
*
|
1989-11-16 |
1992-09-22 |
Lonza Ltd. |
Process for the production of 1-(aminomethyl)cyclohexane acetic acid
|
|
US5084479A
(en)
*
|
1990-01-02 |
1992-01-28 |
Warner-Lambert Company |
Novel methods for treating neurodegenerative diseases
|
|
US5025035A
(en)
*
|
1990-10-12 |
1991-06-18 |
Warner-Lambert Company |
Method of treating depression
|
|
US5792796A
(en)
*
|
1994-07-27 |
1998-08-11 |
Warner-Lambert Company |
Methods for treating anxiety and panic
|
|
US5510381A
(en)
*
|
1995-05-15 |
1996-04-23 |
Warner-Lambert Company |
Method of treatment of mania and bipolar disorder
|
|
HUP9901074A3
(en)
*
|
1996-02-07 |
2001-08-28 |
Warner Lambert Co |
Tetrahydropyrane and tetrahydrothiopyrane aminoacids and pharmaceutical compositions containing them
|
|
SK282848B6
(sk)
*
|
1996-03-14 |
2002-12-03 |
Warner-Lambert Company |
Premostené cyklické aminokyseliny, farmaceutická kompozícia obsahujúca tieto aminokyseliny
|
|
CZ293759B6
(cs)
*
|
1996-03-14 |
2004-07-14 |
Warner-Lambert Company |
Substituovaná cyklická aminokyselina, její použití a farmaceutický prostředek na její bázi
|
|
US6001876A
(en)
|
1996-07-24 |
1999-12-14 |
Warner-Lambert Company |
Isobutylgaba and its derivatives for the treatment of pain
|
|
NZ334898A
(en)
*
|
1996-10-23 |
2000-09-29 |
Warner Lambert Co |
Substituted gamma aminobutyric acids as pharamceutical agents
|
|
IL119890A
(en)
*
|
1996-12-24 |
2002-03-10 |
Teva Pharma |
Gabapentin form iii and preparation of gabapentin form ii
|
|
US6255526B1
(en)
|
1996-12-24 |
2001-07-03 |
Teva Pharmaceutical Industries Ltd. |
Preparation of gabapentin
|
|
US6329429B1
(en)
|
1997-06-25 |
2001-12-11 |
Warner-Lambert Company |
Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases
|
|
HRP980342A2
(en)
*
|
1997-06-25 |
1999-02-28 |
Warner Lambert Co |
Anti-inflammatory method
|
|
US6194459B1
(en)
|
1997-08-19 |
2001-02-27 |
Warner-Lambert Company |
Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants
|
|
EP1011658B1
(fr)
*
|
1997-09-08 |
2005-12-07 |
Warner-Lambert Company Llc |
Compositions analgesiques comprenant des composes anticonvulsivants et leur mode d'utilisation
|
|
WO1999018063A2
(fr)
|
1997-10-07 |
1999-04-15 |
Warner-Lambert Company |
Procede de preparation d'un compose anticonvulsif, aminoacide et cyclique
|
|
KR100589066B1
(ko)
*
|
1997-10-27 |
2006-06-13 |
워너-램버트 캄파니 엘엘씨 |
약제로서 유용한 시클릭 아미노산 및 그의 유도체
|
|
US6984659B2
(en)
*
|
1997-11-18 |
2006-01-10 |
Klinikum Der Albert-Ludwigs Universitaet |
2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
|
|
WO1999031075A1
(fr)
*
|
1997-12-16 |
1999-06-24 |
Warner-Lambert Company |
Derives 1-aminomethyl-cycloalcane substitues en 1 (analogues de =gabapentine), leur preparation et leur utilisation dans le traitement de troubles neurologiques
|
|
KR20010033153A
(ko)
|
1997-12-16 |
2001-04-25 |
로즈 암스트롱, 크리스틴 에이. 트러트웨인 |
4(3)-치환-4(3)-아미노메틸-(티오)피란 또는 -피페리딘유도체(=가바펜틴 동족체), 그의 제법 및 신경 질환 치료용도
|
|
ES2216338T3
(es)
|
1997-12-16 |
2004-10-16 |
Warner-Lambert Company Llc |
Aminas novedosas como agentes farmaceuticos.
|
|
WO1999037296A1
(fr)
*
|
1998-01-23 |
1999-07-29 |
Warner-Lambert Company |
Gabapentine et ses derives pour le traitement de la douleur musculaire et squelettique
|
|
EP0974351A3
(fr)
*
|
1998-04-24 |
2000-12-13 |
Jouveinal |
Médicament pour la prévention et le traitement des dommages gastrointestinaux
|
|
IL139298A0
(en)
|
1998-05-15 |
2001-11-25 |
Warner Lambert Co |
Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
|
|
PL205145B1
(pl)
*
|
1998-05-15 |
2010-03-31 |
Warner Lambert Co |
Trwała kompozycja stała zawierająca pochodną 4-amino-3-podstawionego kwasu butanowego oraz sposób jej wytwarzania
|
|
ES2137137B1
(es)
*
|
1998-05-25 |
2000-08-16 |
Medichem Sa |
Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.
|
|
EP1082306A1
(fr)
|
1998-05-26 |
2001-03-14 |
Warner-Lambert Company |
Composes d'acide amines soumis a une contrainte de conformation et presentant une affinite pour la sous-unite alpha 2 delta d'un canal calcique
|
|
ITMI981535A1
(it)
*
|
1998-07-03 |
2000-01-03 |
Zambon Spa |
Processo per la preparazione di gabapentina
|
|
US20030045500A1
(en)
*
|
1998-07-09 |
2003-03-06 |
Leslie Magnus |
Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles
|
|
FR2781793B1
(fr)
|
1998-08-03 |
2001-07-20 |
Prographarm Lab |
Procede de fabrication de granules de gabapentine enrobes
|
|
HU225502B1
(en)
*
|
1998-12-29 |
2007-01-29 |
Richter Gedeon Vegyeszet |
Process for producing 1-(amino-metyl)-cyclohexene-acetic-acid and intermediates
|
|
IT1311984B1
(it)
|
1999-03-26 |
2002-03-22 |
Bioindustria Lab Italiano Medi |
Procedimento per la preparzione di gabapentin.
|
|
WO2000061188A1
(fr)
*
|
1999-04-09 |
2000-10-19 |
Euro-Celtique S.A. |
Composition de blocage du canal sodique et leur utilisation
|
|
AU4673200A
(en)
*
|
1999-05-28 |
2000-12-18 |
Warner-Lambert Company |
3-heteroarylalkyl substituted gaba analogs
|
|
US6710190B1
(en)
*
|
1999-05-28 |
2004-03-23 |
Warner-Lambert Company |
3-heteroarylalkyl substituted gaba analogs
|
|
US7164034B2
(en)
*
|
1999-06-10 |
2007-01-16 |
Pfizer Inc. |
Alpha2delta ligands for fibromyalgia and other disorders
|
|
US20080207755A1
(en)
*
|
2000-05-31 |
2008-08-28 |
Pfizer Inc |
Alpha 2 Delta Ligands For Fibromyalgia and Other Disorders
|
|
CA2374755C
(fr)
*
|
1999-06-10 |
2010-03-30 |
Warner-Lambert Company |
Acides 3-propyle gamma-aminobutyriques monosubstitues et disubstitues
|
|
US6294198B1
(en)
|
1999-08-24 |
2001-09-25 |
Purepac Pharmaceutical Co. |
Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same
|
|
HN2000000224A
(es)
*
|
1999-10-20 |
2001-04-11 |
Warner Lambert Co |
Aminoacidos biciclicos como agentes farmaceuticos
|
|
GB2362646A
(en)
*
|
2000-05-26 |
2001-11-28 |
Warner Lambert Co |
Cyclic amino acid derivatives useful as pharmaceutical agents
|
|
EP1289364B1
(fr)
|
2000-06-16 |
2003-12-10 |
Teva Pharmaceutical Industries Ltd. |
Gabapentine stable contenant plus de 20 ppm d'ions chlore
|
|
EP1384473A1
(fr)
*
|
2000-06-16 |
2004-01-28 |
Teva Pharmaceutical Industries Ltd. |
Gabapentin stable contenant plus de 20 ppm d'ions chlore
|
|
AU2001266992B8
(en)
*
|
2000-06-16 |
2005-12-01 |
Teva Pharmaceutical Industries Ltd. |
Stable gabapentin having pH within a controlled range
|
|
ATE390133T1
(de)
*
|
2000-06-26 |
2008-04-15 |
Warner Lambert Co |
Gabapentinanaloga für schlafstörungen
|
|
GB2364049A
(en)
*
|
2000-06-28 |
2002-01-16 |
Warner Lambert Co |
Cyclic ketones and their use in the synthesis of amino acids
|
|
ES2252310T3
(es)
*
|
2000-09-14 |
2006-05-16 |
Grunenthal Gmbh |
Beta-tioaminoacidos.
|
|
AU2002211863A1
(en)
*
|
2000-10-06 |
2002-04-15 |
Xenoport, Inc. |
Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
|
|
EP1361847A2
(fr)
*
|
2000-10-06 |
2003-11-19 |
Xenoport, Inc. |
Conjugues d'acides biliaires permettant de fournir des concentrations systemiques regulieres de medicaments
|
|
US6620829B2
(en)
*
|
2000-10-17 |
2003-09-16 |
Warner-Lambert Company |
Method of treating noninflammatory cartilage damage
|
|
IT1319234B1
(it)
*
|
2000-10-23 |
2003-09-26 |
Zambon Spa |
Processo di preparazione di gabapentina.
|
|
GB2368579A
(en)
*
|
2000-10-31 |
2002-05-08 |
Parke Davis & Co Ltd |
Azole pharmaceutical agents
|
|
CN1471507A
(zh)
*
|
2000-11-02 |
2004-01-28 |
������ҩ��ҵ����˾ |
用于制备加巴喷丁中间体的改进方法
|
|
IL155704A0
(en)
*
|
2000-11-30 |
2003-11-23 |
Pfizer Prod Inc |
Combination of gaba agonists and sorbitol dehydrogenase inhibitors
|
|
HRP20030419A2
(en)
*
|
2000-11-30 |
2004-08-31 |
Pfizer Prod Inc |
Combination of gaba agonists and aldose reductase inhibitors
|
|
IT1319674B1
(it)
*
|
2000-12-01 |
2003-10-23 |
Erregierre Spa |
Processo per la preparazione dell'acido1-(aminometil)cicloesanacetico.
|
|
JP2004524339A
(ja)
*
|
2001-03-16 |
2004-08-12 |
ソルケム イタリアーナ エス．ピー．エイ． |
環状アミノ酸の調製方法
|
|
ITMI20011132A1
(it)
|
2001-05-29 |
2002-11-29 |
Procos Spa |
Procedimento per la preparazione dell'acido 1-amminometil-1-cicloesanacetico
|
|
US8048917B2
(en)
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US7232924B2
(en)
*
|
2001-06-11 |
2007-06-19 |
Xenoport, Inc. |
Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
|
|
MXPA03011566A
(es)
*
|
2001-06-11 |
2004-10-28 |
Xenoport Inc |
Formas de dosificacion de profarmacos de analogos de gaba administrados oralmente que tienen toxicidad reducida.
|
|
US7420002B2
(en)
*
|
2001-06-11 |
2008-09-02 |
Xenoport |
Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
|
|
US7186855B2
(en)
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US6818787B2
(en)
|
2001-06-11 |
2004-11-16 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
IL144066A0
(en)
*
|
2001-06-28 |
2002-04-21 |
Bromine Compounds Ltd |
Process for the preparation of 1,1-cyclohexane diacetic monoamide
|
|
ITMI20011772A1
(it)
|
2001-08-10 |
2003-02-10 |
A M S A Anonima Materie Sint E |
Processo per la preparazione della 2,5-bis-(2,2,2-trifluoroetossi)-n-(2-piperidilmetil)-benzamide(flecainide)
|
|
SI1423168T1
(sl)
|
2001-09-03 |
2006-06-30 |
Newron Pharm Spa |
Farmacevtski sestavek, ki vsebuje gabapentin ali njegov analog in alfa-aminoamid, in njegova analgetska uporaba
|
|
US6800782B2
(en)
*
|
2001-10-09 |
2004-10-05 |
Warner-Lambert Co. |
Anhydrous crystalline forms of gabapentin
|
|
US20070184104A1
(en)
*
|
2001-10-25 |
2007-08-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
|
TWI312285B
(en)
*
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
|
US20060159743A1
(en)
*
|
2001-10-25 |
2006-07-20 |
Depomed, Inc. |
Methods of treating non-nociceptive pain states with gastric retentive gabapentin
|
|
US7612112B2
(en)
|
2001-10-25 |
2009-11-03 |
Depomed, Inc. |
Methods of treatment using a gastric retained gabapentin dosage
|
|
US20030119908A1
(en)
*
|
2001-12-21 |
2003-06-26 |
Zambon Group S.P.A. |
Stable gabapentin compositions
|
|
ITMI20012750A1
(it)
|
2001-12-21 |
2003-06-21 |
Procos Spa |
Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura
|
|
EP1469841A1
(fr)
*
|
2002-01-31 |
2004-10-27 |
Warner-Lambert Company |
Ligands alpha 2 delta dans le traitement des acouphenes
|
|
US6682759B2
(en)
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
|
US6927036B2
(en)
*
|
2002-02-19 |
2005-08-09 |
Xero Port, Inc. |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
|
|
US7026351B2
(en)
*
|
2002-03-20 |
2006-04-11 |
Xenoport, Inc. |
Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof
|
|
EP1494996A1
(fr)
*
|
2002-04-16 |
2005-01-12 |
Taro Pharmaceutical Industries Limited |
Procede pour l'elaboration de gabapentine
|
|
WO2003094842A2
(fr)
*
|
2002-05-07 |
2003-11-20 |
A & D Bioscience, Inc. |
Conjugues comprenant un medicament agissant sur le systeme nerveux central, lequel medicament est lie a un acide glucuronique ou a une glucosamine par l'intermediaire d'une liaison amide, et utilisations correspondantes
|
|
AU2003243180A1
(en)
*
|
2002-05-17 |
2003-12-12 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
EP1515709A2
(fr)
*
|
2002-06-27 |
2005-03-23 |
Warner-Lambert Company LLC |
Methode de traitement du trouble d'hyperactivite avec deficit de l'attention
|
|
CA2395931A1
(fr)
*
|
2002-08-07 |
2004-02-07 |
Bernard Charles Sherman |
Compositions solides comportant du gabapentin et ayant une meilleure stabilite
|
|
US7053122B2
(en)
*
|
2002-08-09 |
2006-05-30 |
Pfizer Inc |
Therapeutic use of aryl amino acid derivatives
|
|
US7419981B2
(en)
*
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
|
US20040092591A1
(en)
*
|
2002-08-15 |
2004-05-13 |
Blakemore David Clive |
Therapeutic use of fused bicyclic or tricyclic amino acids
|
|
US20040092522A1
(en)
*
|
2002-08-15 |
2004-05-13 |
Field Mark John |
Synergistic combinations
|
|
US20040092498A1
(en)
*
|
2002-08-16 |
2004-05-13 |
David Blakemore |
Substituted glycine derivatives for use as medicaments
|
|
ITMI20022071A1
(it)
*
|
2002-10-01 |
2004-04-02 |
Erregierre Spa |
Processo di sintesi dell'acido 1-(aminometil)cicloesanacetico cloridato.
|
|
US7659305B2
(en)
*
|
2002-10-31 |
2010-02-09 |
Pfizer Inc. |
Therapeutic proline derivatives
|
|
ATE418535T1
(de)
*
|
2002-11-18 |
2009-01-15 |
Nicholas Piramal India Ltd |
Verbessertes verfahren zur herstellung von gabapentin
|
|
ES2334119T3
(es)
*
|
2002-11-20 |
2010-03-05 |
Hikal Ltd. |
Procedimiento mejorado para la fabricacion de gabalactama.
|
|
AU2003297909A1
(en)
*
|
2002-12-11 |
2004-06-30 |
Xenoport, Inc. |
Orally administered dosage forms of fused gaba analog prodrugs having reduced toxicity
|
|
US7060727B2
(en)
*
|
2002-12-11 |
2006-06-13 |
Xenoport, Inc. |
Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof
|
|
US20040180958A1
(en)
*
|
2002-12-13 |
2004-09-16 |
Taylor Charles Price |
Method of treatment
|
|
AU2003283718A1
(en)
*
|
2002-12-13 |
2004-07-09 |
Warner-Lambert Company Llc |
Gabapentin analogues for fibromyalgia and other related disorders
|
|
CN101862317A
(zh)
*
|
2002-12-13 |
2010-10-20 |
沃尼尔·朗伯有限责任公司 |
用于治疗纤维肌痛和其它疾病的普加巴林衍生物
|
|
MXPA05006209A
(es)
*
|
2002-12-13 |
2005-08-19 |
Warner Lambert Co |
Pregabalina y sus derivados para el tratamiento de fibromialgia y otros trastornos relacionados.
|
|
CA2451267A1
(fr)
*
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Utilisations pharmaceutiques de ligands alpha2delta
|
|
DE60332387D1
(de)
|
2002-12-13 |
2010-06-10 |
Warner Lambert Co |
Alpha-2-delta-ligand zur behandlung vonsymptomen der unteren harnwege
|
|
GB0301143D0
(en)
*
|
2003-01-17 |
2003-02-19 |
Amedis Pharm Ltd |
Compounds and their use
|
|
RU2312853C2
(ru)
*
|
2003-01-22 |
2007-12-20 |
Уорнер-Ламберт Компани Ллс |
ПРОИЗВОДНЫЕ ЦИКЛОПРОПИЛ-β-АМИНОКИСЛОТЫ
|
|
JP2006519831A
(ja)
*
|
2003-03-07 |
2006-08-31 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
テトラゾール及びオキサジアゾロン置換β−アミノ酸誘導体
|
|
WO2004093866A1
(fr)
*
|
2003-03-25 |
2004-11-04 |
Kiel Laboratories, Inc. |
Procede permettant de preparer des sels d'acide phenolique de gabapentine
|
|
WO2004093827A2
(fr)
*
|
2003-03-25 |
2004-11-04 |
Kiel Laboratories, Inc. |
Sels d'acide phenolique de gabapentine en formes posologiques solides et procedes d'utilisation
|
|
EP1628656B1
(fr)
*
|
2003-03-25 |
2008-10-15 |
Kiel Laboratories, Inc. |
Tannate de gabapentine sous une forme galenique liquide ou semi-solide
|
|
MXPA05010515A
(es)
*
|
2003-03-31 |
2006-03-10 |
Xenoport Inc |
Tratamiento o prevencion de sofocos calientes utilizando profarmacos de analogos de gaba.
|
|
WO2004091278A2
(fr)
*
|
2003-04-11 |
2004-10-28 |
Transform Pharmaceuticals, Inc. |
Compositions de gabapentine
|
|
ITMI20030825A1
(it)
*
|
2003-04-18 |
2004-10-19 |
Farchemia Srl |
Procedimento per la preparazione di gabapentin esente da
|
|
EP1615875A2
(fr)
*
|
2003-04-21 |
2006-01-18 |
Matrix Laboratories Limited |
Processus de preparation de gabapentine forme ii
|
|
EP1633400A2
(fr)
*
|
2003-05-16 |
2006-03-15 |
Pfizer Products Inc. |
Combinaisons therapeutiques d'antipsychotiques atypiques avec des modulateurs de l'acide 4-aminobutanoique et/ou des medicaments anticonvulsivants
|
|
CA2528388A1
(fr)
*
|
2003-06-19 |
2004-12-23 |
Pfizer Products Inc. |
Preparation biocatalytique d'acide 1-cyanocyclohexane acetique
|
|
US7169812B2
(en)
*
|
2003-07-01 |
2007-01-30 |
Medtronic, Inc. |
Process for producing injectable gabapentin compositions
|
|
CA2572324A1
(fr)
*
|
2003-07-02 |
2005-01-13 |
Warner-Lambert Company Llc |
Combinaison d'un inhibiteur allosterique de la metalloproteinase-13 matricielle et d'un ligand au recepteur alpha-2-delta
|
|
US20050013863A1
(en)
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
|
WO2005046566A2
(fr)
*
|
2003-08-04 |
2005-05-26 |
Sun Pharmaceutical Industries Limited |
Composition pharmaceutique stable
|
|
US20050043407A1
(en)
*
|
2003-08-22 |
2005-02-24 |
Pfizer Inc |
Pharmaceutical composition for the prevention and treatment of addiction in a mammal
|
|
KR20060119971A
(ko)
*
|
2003-09-11 |
2006-11-24 |
제노포트 인코포레이티드 |
Ｇａｂａ 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방
|
|
DE602004024317D1
(de)
|
2003-09-12 |
2010-01-07 |
Pfizer |
Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
|
|
KR20060087560A
(ko)
*
|
2003-09-12 |
2006-08-02 |
워너-램버트 캄파니 엘엘씨 |
알파-2-델타 리간드 및 ｓｓｒｉ 및/또는 ｓｎｒｉ를포함하는 우울증 및 불안 장애 치료용 조합물
|
|
WO2005027850A2
(fr)
*
|
2003-09-17 |
2005-03-31 |
Xenoport, Inc. |
Traitement ou prevention du syndrome des jambes sans repos a l'aide de promedicaments a base d'analogues du gaba
|
|
MXPA06004088A
(es)
*
|
2003-10-14 |
2006-06-27 |
Xenoport Inc |
Forma cristalina de un analogo del acido gamma-aminobutirico.
|
|
ITMI20032165A1
(it)
*
|
2003-11-11 |
2005-05-12 |
Zambon Spa |
Processo di preparazione di gabapentina
|
|
WO2005060968A1
(fr)
|
2003-12-11 |
2005-07-07 |
Sepracor Inc. |
Combinaison d'un sedatif et d'un modulateur des neurotransmetteurs, et methodes permettant d'ameliorer la qualite du sommeil et de traiter la depression
|
|
CA2553291A1
(fr)
*
|
2004-01-29 |
2005-09-09 |
Pfizer Products Inc. |
Combinaison de modulateurs d'acide .gamma.-aminobutyrique et d'antagonistes du recepteur 5-ht1b
|
|
US20050187295A1
(en)
*
|
2004-02-19 |
2005-08-25 |
Surendra Kalyan |
Processes for the preparation of gabapentin
|
|
CA2570255A1
(fr)
*
|
2004-03-17 |
2005-09-22 |
Hikal Limited |
4-t-butylgabapentine et synthese de ce compose
|
|
ITMI20040579A1
(it)
*
|
2004-03-25 |
2004-06-25 |
Zambon Spa |
Processo di preparazione di gabapentina
|
|
CA2567249A1
(fr)
*
|
2004-04-19 |
2006-10-05 |
Jds Pharmaceuticals, Llc |
Combinaisons de lithium et utilisations associees
|
|
KR20070029740A
(ko)
*
|
2004-06-09 |
2007-03-14 |
화이자 인코포레이티드 |
통증 치료를 위한 레복세틴의 용도
|
|
GB0416228D0
(en)
*
|
2004-07-20 |
2004-08-25 |
Sandoz Ind Products S A |
Process for the preparation of gabapentin
|
|
GB0419849D0
(en)
*
|
2004-09-07 |
2004-10-13 |
Pfizer Ltd |
Pharmaceutical combination
|
|
US20080096965A1
(en)
*
|
2004-09-10 |
2008-04-24 |
Newron Pharmaceuticals S.P.A. |
(Halobenzyloxy) Benzylamino-Propanamides as Sodium and/or Calcium Channel Selective Modulators
|
|
EP1811986B1
(fr)
|
2004-11-04 |
2014-03-26 |
XenoPort, Inc. |
Formes posologiques orales a liberation prolongee d'un promedicament de la gabapentine
|
|
JP2009506069A
(ja)
|
2005-08-26 |
2009-02-12 |
ブレインセルス，インコーポレイティド |
ムスカリン性受容体調節による神経発生
|
|
EP2258359A3
(fr)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline
|
|
US8378096B2
(en)
*
|
2005-09-23 |
2013-02-19 |
Janssen Pharmaceutica N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
|
US7825151B2
(en)
*
|
2005-09-23 |
2010-11-02 |
Janssen Pharmaceutica Nv |
Hexahydro-cyclooctyl pyrazole cannabinoid modulators
|
|
PL1931335T3
(pl)
*
|
2005-09-23 |
2010-07-30 |
Janssen Pharmaceutica Nv |
Modulatory heksahydrocyklooktylopirazolokannabinoidowe
|
|
HRP20120159T1
(hr)
*
|
2005-09-23 |
2012-03-31 |
Janssen Pharmaceutica Nv |
Modulatori heksahidro-cikloheptapirazol kanabinoida
|
|
US8378117B2
(en)
*
|
2005-09-23 |
2013-02-19 |
Janssen Pharmaceutica N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
|
US7790718B2
(en)
*
|
2005-09-23 |
2010-09-07 |
Janssen Pharmaceutica Nv |
Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
|
|
US7985756B2
(en)
|
2005-10-21 |
2011-07-26 |
Braincells Inc. |
Modulation of neurogenesis by PDE inhibition
|
|
WO2007053596A1
(fr)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Modulation de la neurogenese dont la mediation est assuree par recepteur gaba
|
|
US20070117858A1
(en)
*
|
2005-11-23 |
2007-05-24 |
Mingde Xia |
Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators
|
|
US20090176882A1
(en)
*
|
2008-12-09 |
2009-07-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
|
WO2007092456A2
(fr)
*
|
2006-02-03 |
2007-08-16 |
Rolls-Royce Corporation |
Systeme de carburant de moteur a turbine a gaz dote d'une soupape doseuse de carburant
|
|
EP1820502A1
(fr)
|
2006-02-10 |
2007-08-22 |
Laboratorios Del Dr. Esteve, S.A. |
Combinaisons de principes actifs comprenant de dérivés d' azolylcarbinol
|
|
WO2007095513A1
(fr)
*
|
2006-02-14 |
2007-08-23 |
Janssen Pharmaceutica, Nv |
Modulateurs cannabinoides de type tetrahydro-2h-indazole pyrazole
|
|
KR20080100284A
(ko)
*
|
2006-03-06 |
2008-11-14 |
화이자 프로덕츠 인코포레이티드 |
비-회복성 수면을 위한 알파-2-델타 리간드
|
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
|
US20070254911A1
(en)
*
|
2006-03-27 |
2007-11-01 |
Mingde Xia |
Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
|
|
US8012957B2
(en)
*
|
2006-03-27 |
2011-09-06 |
Janssen Pharmaceutica Nv |
Tetrahydro-1H-1,2,6-triaza-azulene cannabinoid modulators
|
|
WO2007134077A2
(fr)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenèse induite par le récepteur 5ht
|
|
WO2007134136A2
(fr)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenèse par modulation de l'angiotensine
|
|
US7442834B2
(en)
*
|
2006-06-12 |
2008-10-28 |
Zhejiang Chiral Medicine Chemicals Co., Ltd. |
Process suitable for industrial scale production of gabapentin
|
|
US8143443B2
(en)
*
|
2006-06-30 |
2012-03-27 |
Zach System S.P.A. |
Process for preparing gabapentin
|
|
EP2068872A1
(fr)
|
2006-09-08 |
2009-06-17 |
Braincells, Inc. |
Combinaisons contenant un dérivé de 4-acylaminopyridine
|
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
|
BRPI0720252A2
(pt)
*
|
2006-12-08 |
2014-01-07 |
Xenoport Inc |
Uso de pró-fármacos de análogos de gaba para tratar doenças
|
|
ATE511860T1
(de)
|
2006-12-22 |
2011-06-15 |
Recordati Ireland Ltd |
Kombinationstherapie für erkrankungen der unteren harnwege mit 2 liganden und nsar
|
|
JP2010521453A
(ja)
*
|
2007-03-15 |
2010-06-24 |
サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド |
新規プロドラッグ
|
|
WO2008157408A2
(fr)
*
|
2007-06-15 |
2008-12-24 |
Xenoport, Inc. |
Utilisation de promédicaments d'analogues de gaba, agents antispasticité et promédicaments d'agonistes de récepteur de gaba b pour traiter la spasticité
|
|
US7943653B2
(en)
*
|
2007-08-13 |
2011-05-17 |
Janssen Pharmaceutica N.V. |
Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
|
|
US20090062392A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched gabapentin
|
|
WO2009061934A1
(fr)
*
|
2007-11-06 |
2009-05-14 |
Xenoport, Inc. |
Utilisation de promédicaments d'agonistes de gaba b pour le traitement de douleur neuropathique et musculo-squelettique
|
|
US7872046B2
(en)
*
|
2008-01-25 |
2011-01-18 |
Xenoport, Inc. |
Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
|
|
WO2009094577A2
(fr)
|
2008-01-25 |
2009-07-30 |
Xenoport, Inc. |
Formes mésophasiques de précurseurs d'acide (3s)-aminométhyl-5-méthyl-hexanoïque et procédés d'utilisation
|
|
EP2250143B1
(fr)
*
|
2008-01-25 |
2016-04-20 |
XenoPort, Inc. |
Resolution cinetique enzymatique de thiocarbonates d'acyloxyalkyle utilises dans la synthese de carbamates d'acyloxyalkyle
|
|
EP2116539A1
(fr)
|
2008-04-25 |
2009-11-11 |
Laboratorios Del. Dr. Esteve, S.A. |
1-aryl-3-aminoalkoxy-pyrazoles en tant que ligands améliorant les effets analgésiques des opioïdes et réduisant leur dépendance
|
|
US20100190752A1
(en)
*
|
2008-09-05 |
2010-07-29 |
Gruenenthal Gmbh |
Pharmaceutical Combination
|
|
ES2589915T3
(es)
|
2008-10-08 |
2016-11-17 |
Xgene Pharmaceutical Inc |
Conjugados de GABA y métodos de utilización de los mismos
|
|
WO2010099200A1
(fr)
|
2009-02-24 |
2010-09-02 |
Nektar Therapeutics |
Conjugués oligomère-acides aminés
|
|
WO2010099217A1
(fr)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine
|
|
US20110124705A1
(en)
*
|
2009-11-24 |
2011-05-26 |
Xenoport, Inc. |
Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
|
US20110130454A1
(en)
*
|
2009-11-24 |
2011-06-02 |
Xenoport, Inc. |
Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
|
EP2509596B1
(fr)
|
2009-12-08 |
2019-08-28 |
Case Western Reserve University |
Gamma acides aminés pour le traitement de troubles oculaires
|
|
EP2353591A1
(fr)
|
2010-02-04 |
2011-08-10 |
Laboratorios Del. Dr. Esteve, S.A. |
Ligands sigma pour la potentialisation de l'effet analgésique d'opioïdes et d'opiacés dans la douleur post-opératoire et en atténuant la dépendance
|
|
EP2368872A1
(fr)
|
2010-03-25 |
2011-09-28 |
Serichim S.r.l. |
Procédé de préparation de gabapentine
|
|
EP2388005A1
(fr)
|
2010-05-21 |
2011-11-23 |
Laboratorios Del. Dr. Esteve, S.A. |
Ligands sigma pour la prévention et/ou le traitement du vomissement induit par la chimiothérapie ou la radiothérapie
|
|
US20130078290A1
(en)
|
2010-06-01 |
2013-03-28 |
Rubicon Research Private Limited |
Gastroretentive Dosage Forms Of GABA Analogs
|
|
US8431739B2
(en)
|
2010-06-14 |
2013-04-30 |
Divi's Laboratories, Ltd. |
Process for the preparation of gabapentin
|
|
MX2013000946A
(es)
|
2010-07-30 |
2013-02-27 |
Toray Industries |
Agente terapeutico o agente profilactico para el dolor neuropatico.
|
|
EP2415471A1
(fr)
|
2010-08-03 |
2012-02-08 |
Laboratorios Del. Dr. Esteve, S.A. |
Utilisation de ligands sigma dans l'hyperalgie induite par opioïdes
|
|
JP2013216580A
(ja)
*
|
2010-08-06 |
2013-10-24 |
Kyorin Pharmaceutical Co Ltd |
ビシクロ［２．２．２］オクチルアミン誘導体の製造方法
|
|
EP2524694A1
(fr)
|
2011-05-19 |
2012-11-21 |
Laboratorios Del. Dr. Esteve, S.A. |
Utilisation de ligands sigma dans la douleur liée au diabète de type 2
|
|
EP2530072A1
(fr)
|
2011-06-03 |
2012-12-05 |
Lacer, S.A. |
Nouveaux composés, synthèse et utilisation dans le traitement de la douleur
|
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
|
ITMI20131757A1
(it)
|
2013-10-22 |
2015-04-23 |
Zach System Spa |
Processo di preparazione di gabapentina
|
|
JPWO2015064453A1
(ja)
|
2013-11-01 |
2017-03-09 |
株式会社糖鎖工学研究所 |
チオール基を有するｄ−体またはｌ−体アミノ酸誘導体の製造方法
|
|
TW201607538A
(zh)
|
2013-12-17 |
2016-03-01 |
以斯提夫博士實驗室股份有限公司 |
血清素－去甲腎上腺素再攝取抑制劑（ＳＮＲＩＳ）和σ受體配體組合物
|
|
CA2933057A1
(fr)
|
2013-12-17 |
2015-06-25 |
Laboratorios Del Dr. Esteve, S.A. |
Combinaisons de gabapentanoides et de ligands des recepteurs sigma
|
|
WO2015144825A1
(fr)
|
2014-03-27 |
2015-10-01 |
Sanovel Ilac Sanayi Ve Ticaret A.S. |
Solution pharmaceutique liquide orale de gabapentine
|
|
LT3554490T
(lt)
|
2016-12-16 |
2022-04-25 |
Idorsia Pharmaceuticals Ltd |
Farmacinis derinys, apimantis t tipo kalcio kanalo blokatorių
|
|
MX384760B
(es)
|
2018-07-04 |
2025-03-14 |
Federico Amezcua Amezcua |
Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco y gabapentina para el tratamiento del dolor neuropático.
|
|
US10399926B1
(en)
|
2018-08-01 |
2019-09-03 |
Divi's Laboratories Ltd. |
Process for the preparation of gabapentin
|
|
CN112839661A
(zh)
|
2018-10-11 |
2021-05-25 |
萨尼菲特治疗有限公司 |
用于治疗异位钙化的肌醇磷酸酯类
|
|
AU2020370758B2
(en)
*
|
2019-10-25 |
2025-08-14 |
Kyoto University |
Preventative or therapeutic agent for tauopathy
|
|
MX2022010960A
(es)
|
2020-03-04 |
2022-11-16 |
Pleopharma L L C |
Métodos y composiciones para tratar el trastorno por uso de cannabis y mitigar la abstinencia de cannabinoides.
|
|
EP4015494A1
(fr)
|
2020-12-15 |
2022-06-22 |
Sanifit Therapeutics S.A. |
Procédés de préparation de sels solubles de phosphates d'inositol
|
|
GB2625579A
(en)
|
2022-12-21 |
2024-06-26 |
Novumgen Ltd |
An orally disintegrating tablet containing gabapentin or pharmaceutically acceptable salts thereof and the process of preparing the same
|